Immunocore Holdings plc (IMCR)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch IMCR
See up to 3 months of IMCR. The 7-day demo opens the 1M and 3M ranges and puts IMCR on your watchlist.
Start 7-day demoLatest IMCR insider trades
About Immunocore Holdings plc (IMCR)
The SEC lists Immunocore Holdings plc under CIK 0001671927, in biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
IMCR Form 4 activity by transaction type, last 90 days
No Form 4 activity for IMCR in the last 90 days.
IMCR insider transactions (Form 4)
5517 Form 4 filings on record, the earliest from May 15, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Peter John Ratcliffe | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
 Kristine Peterson | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
| William Pao | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
| Siddharth Kaul | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
 Roy Steven Herbst | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
 John Irving Bell | Grant or award | Share Option (Right to Buy) | 27,492 | $0.00 | - | |
| Travis Alan Coy - Officer | Grant or award | Restricted Share Units | 33,353 | $0.00 | - | |
| Travis Alan Coy - Officer | Grant or award | Employee Share Option (Right to Buy) | 95,637 | $0.00 | - | |
| Bahija Jallal - Officer | Option exercise | Ordinary Shares | 23,817 | $0.00 | - | |
| Bahija Jallal - Officer | Open-market sale | Ordinary Shares | 11,474 footnote F2 | $32.35 footnote F3 | $371K | |
| Bahija Jallal - Officer | Option exercise | Restricted Share Units | 23,817 | $0.00 | - | |
| Bahija Jallal - Officer | Grant or award | Restricted Share Units | 88,573 | $0.00 | - | |
| Bahija Jallal - Officer | Grant or award | Employee Share Option (Right to Buy) | 395,066 | $0.00 | - | |
| ||||||
| John Goll - Officer | Option exercise | Restricted Share Units | 1,351 | $0.00 | - | |
| John Goll - Officer | Grant or award | Restricted Share Units | 7,411 | $0.00 | - | |
| John Goll - Officer | Option exercise | Ordinary Shares | 1,351 | $0.00 | - | |
| John Goll - Officer | Open-market sale | Ordinary Shares | 698 footnote F2 | $32.35 footnote F3 | $23K | |
| John Goll - Officer | Grant or award | Employee Share Option (Right to Buy) | 21,252 | $0.00 | - | |
| ||||||
| Leger Tina Amber St - Officer | Option exercise | Ordinary Shares | 2,119 | $0.00 | - | |
| Leger Tina Amber St - Officer | Open-market sale | Ordinary Shares | 1,000 footnote F2 | $32.35 footnote F3 | $32K | |
| Leger Tina Amber St - Officer | Option exercise | Restricted Share Units | 2,119 | $0.00 | - | |
| ||||||
 David M. Berman - Officer | Option exercise | Ordinary Shares | 11,824 | $0.00 | - | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 5,965 footnote F2 | $32.35 footnote F3 | $193K | |
| David M. Berman - Officer | Option exercise | Restricted Share Units | 11,824 | $0.00 | - | |
| ||||||
| David M. Berman - Officer | Option exercise | Ordinary Shares | 69,404 | $17.46 | $1.21M | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 69,404 | $40.12 footnote F2 | $2.78M | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 5,521 | $17.46 | $96K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 5,521 | $40.09 footnote F3 | $221K | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 69,404 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 5,521 | $0.00 | - | |
| ||||||
| David M. Berman - Officer | Option exercise | Ordinary Shares | 100 | $17.46 | $2K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 100 | $40.00 | $4K | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 18,020 | $17.46 | $315K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 18,020 | $40.03 footnote F2 | $721K | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 100 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 18,020 | $0.00 | - | |
| ||||||
| David M. Berman - Officer | Option exercise | Ordinary Shares | 61,849 | $17.46 | $1.08M | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 61,849 | $35.23 | $2.18M | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 61,849 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 22,532 | $17.46 | $393K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 21,232 | $35.63 | $756K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 1,300 | $36.31 | $47K | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 200 | $17.46 | $3K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 200 | $35.01 | $7K | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 22,532 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 200 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 31,338 | $17.46 | $547K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 30,138 | $36.12 | $1.09M | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 1,200 | $36.77 | $44K | |
| David M. Berman - Officer | Option exercise | Ordinary Shares | 19,081 | $17.46 | $333K | |
| David M. Berman - Officer | Open-market sale | Ordinary Shares | 19,081 | $36.28 | $692K | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 31,338 | $0.00 | - | |
| David M. Berman - Officer | Option exercise | Employee Share Option (Right to Buy) | 19,081 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Share Option (right to buy) | 26,198 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Share Option (right to buy) | 26,198 | $0.00 | - | |
Item 7.01, 9.01
Item 2.02, 9.01
Item 5.07
Item 2.02, 9.01
Recent IMCR Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
IMCR insider trading FAQ
What is the latest insider trade for IMCR?
Immunocore Holdings plc (IMCR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-28. The full record for IMCR runs to 17 Form 4 filings, the earliest from 2025-05-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMCR stock?
No insider purchases of IMCR were filed in the last 90 days.
How many insiders are selling IMCR stock?
No insider sales of IMCR were filed in the last 90 days. 15 sales are on record for this company.
Where can I see IMCR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMCR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Peter John Ratcliffe view on EDGAR
- - Kristine Peterson view on EDGAR
- - William Pao view on EDGAR
- - Siddharth Kaul view on EDGAR
- - Roy Steven Herbst view on EDGAR
- - John Irving Bell view on EDGAR
- - Travis Alan Coy view on EDGAR
- - Bahija Jallal view on EDGAR
- - John Goll view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where IMCR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMCR with a 7-day demo
- IMCR on your watchlist
- Every IMCR Form 4 filing on record
- Up to 3 months of IMCR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
